Get started
Work

Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: A phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51

Year: 2007
Type: article
Study design: Clinical Trial
DOI: 10.1080/10428190701355028
Authors: David M. Kurtz, Loren K. Tschetter, Jacob B. Allred, Susan M. Geyer, Paul J. Kurtin, Wesley D. Putnam, Kendrith M. Rowland, Martin Wiesenfeld, Gamini S. Soori, Richard C. Tenglin, Albert M. Bernath, Thomas E. Witzig
Language: English
Field: Medicine
Open Access status: closed
Awards: G1109514914, G1423238671, G1539327064, G179864828, Illinois Oncology Research Association Community Clinical Oncology Program, Sanford Community Cancer Consortium, G2082142344, G2440672419, G248987615, Geisinger Clinical Oncology Program, G358241105, G42877212, Community Clinical Oncology Program, North Central Cancer Treatment Group, Cedar Rapids Oncology Project, Carle Cancer Center Community Clinical Oncology Program, Missouri Valley Cancer Consortium CCOP, G688707633, Duluth Community Clinical Oncology Program, G844520391, Scottsdale Community Clinical Oncology Program, Mayo Clinic Comprehensive Cancer Center Support Grant
OpenAlex ID: W1994739736
FWCI: 1.893
Cites: 44
Cited by: 23
Related to: 10